Ophthalmic Artery and Retinal Vascular Metrics as Predictive Biomarkers for Placental Insufficiency

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

September 30, 2026
Response Due
Active
Status

Opportunity Overview

During pregnancy, there are dramatic changes within a women's cardiovascular system (heart and blood vessels), including a large increase in her total blood volume and redistribution of blood flow to various organs. This helps to increase the amount of blood supplying the placenta, the structure which provides oxygen and nutrients to the baby via the umbilical cord.
Sometimes this process can go awry, resulting in problems for mothers such as dangerously high blood pressure and organ damage (pre-eclampsia). Babies who do not receive sufficient oxygen and nutrition through the placenta are at risk of not growing at a healthy rate (fetal growth restriction), or even of dying inside the womb (stillbirth). Pre-eclampsia and fetal growth restriction are common reasons for babies needing to be born early, which can increase their chances of both short and long-term health problems.
Taking aspirin during pregnancy can help to improve the blood supply to the placenta in women at increased risk of these conditions. However, once pre-eclampsia or fetal growth restriction develop, the only "treatment" is for the baby to be born. Currently, we do not have reliable methods for identifying women who are most likely to develop poor placental blood supply, and it is difficult to detect problems until they are causing dangerous issues for mother or baby.
In recent years, there have been great advances in the ability of scientists to develop "digital twins". These are computational models which combine large amounts of data about an individual to create a virtual replica of biological systems and processes within that person.
During this project, I plan to collect detailed measurements from pregnant women and use these to develop personalised "digital twins" of the cardiovascular system. This will allow me to study how the blood supply to the placenta, and the distribution of blood flow throughout the body, change during pregnancy for individual...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedOctober 01, 2024
Procurement stageActive solicitation
Response dueSeptember 30, 2026
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.